Australia's Healius jumps on review, CEO change

Australian Clinical Labs

04/03/2024 23:34

March 5 (Reuters) - Healius'  HLS.AX  shares jumped more
than 11% on Tuesday after the healthcare firm said it would
start a review and engage investment advisers after Australia's
competition regulator killed the $1 billion takeover by rival
Australian Clinical Labs  ACL.AX  last year.
    Healius also said Chief Financial Officer Paul Anderson will
transition to the CEO role, replacing Maxine Jaquet.

 (Reporting by Ayushman Ojha; Editing by Alan Barona)
 ((Ayushman.Ojha@thomsonreuters.com;))